Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3):250-64

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  NUCLEAR MEDICINE IN PRECISION ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3):250-64

DOI: 10.23736/S1824-4785.20.03264-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy

Maaike DOTINGA 1 ✉, Dennis VRIENS 1, Floris van VELDEN 1, Linda HEIJMEN 1, James NAGARAJAH 2, 3, Rodney HICKS 4, Ellen KAPITEIJN 5, Lioe-Fee de GEUS-OEI 1, 6

 

ACCESS OPTIONS

Purchase access

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of  € 45,00.

Downloading and printing for personal use allowed.

Regain access


Personal subscriptions

Access as an individual subscriber


Institutional access

Access through your institution

Subscribe to this journal

Subscribe to The Quarterly Journal of Nuclear Medicine and Molecular Imaging


Recommend to your librarian

top of page

 

Copyright © 2025 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions